Loss of heterozygosity of CDKN2A (p16INK4a) and RB1 tumor suppressor genes in testicular germ cell tumors

Fombonne J, Devouassoux-Shisheboran M, Bouvier R, Droz J-P, Benahmed M, Krantic S. Analysis of p16INK4A gene promoter in male germ-cell tumors: identification of a new point mutation. Cancer Detect Prev 2005; 29: 1-7.10.1016/j.cdp.2004.08.005Search in Google Scholar

Kachanov DY, Dobrenkov KV, Shamanskaya TV, Abdullaev RT, Inushkina EV, Savkova RF. Solid tumors in young children in Moscow Region of Russian Federation. Radiol Oncol 2008; 42: 39-44.10.2478/v10019-007-0037-2Search in Google Scholar

Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Tumours of the testis and paratesticular tissue. In: Kleihues P, Sobin LH, editors. World Health Organization Classification of Tumour. Lyon: IARC Press; 2004. p. 217-78.Search in Google Scholar

Bergthorsson JT, Agnarsson BA, Gudbjartsson T, Magnusson K, Thoroddsen A, Palsson B, et al. A genome-wide study of allelic imbalance in human testicular germ cell tumors using microsatellite markers. Cancer Genet Cytogenet 2006; 164: 1-9.10.1016/j.cancergencyto.2005.06.015Search in Google Scholar

von Eyben FE. Chromosomes, genes, and development of testicular germ cell tumors. Cancer Genet Cytogenet 2004; 151: 93-138.10.1016/j.cancergencyto.2003.09.008Search in Google Scholar

Bartek J, Bartkova J, Lukas J. The retinoblastoma protein pathway in cell cycle control and cancer. Exp Cell Res 1997; 237: 1-6.10.1006/excr.1997.3776Search in Google Scholar

Bartkova J, Rajpert-De Meyts E, Skakkebæk NE, Lukas J, Bartek J. Deregulation of the G1/S-phase control in human testicular germ cell tumours. APMIS 2003; 111: 252-66.10.1034/j.1600-0463.2003.1110129.xSearch in Google Scholar

Adams PD, Li X, Sellers WR, Baher KB, Leng X, Harper JW, et al. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complex. Mol Cell Biol 1999; 19: 1068-80.10.1128/MCB.19.2.1068Search in Google Scholar

Parry D, Mahony D, Willis K, Lees E. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol Cell Biol 1999; 19: 1775-83.10.1128/MCB.19.3.1775Search in Google Scholar

Sherr CJ. Cancer cell cycles. Science 1996; 274: 1672-77.10.1126/science.274.5293.1672Search in Google Scholar

Zhang HS, Postigo AA, Dean DC., Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFβ, and contact inhibition. Cell 1999; 97: 53-61.10.1016/S0092-8674(00)80714-XSearch in Google Scholar

Bartkova J, Lukas C, Sørensen CS, Rajpert-De Meyts E, Skakkebæk NE, Lukas J, et al. Deregulation of the RB pathway in human testicular germ cell tumours. J Pathol 2003; 200: 149-56.10.1002/path.1353Search in Google Scholar

Schmidt BA, Rose A, Steinhoff C, Strohmeyer T, Hartman M, Ackermann R. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors. Cancer Res 2001; 61: 4214-21.Search in Google Scholar

Herranz M, Urioste M, Santos J, Rivas C, Martinez B, Benitez J, et al. Analysis of the INK4a/ARF locus in non-Hodkin's lymphomas using two new internal microsatellite markers. Leukemia 1999; 13: 808-10.10.1038/sj.leu.2401409Search in Google Scholar

Xing EP, Yang G-Y, Wang L-D, Shi ST, Yang CS. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer. Clin Cancer Res 1999; 5: 1231-40.Search in Google Scholar

Jones PA, Laird PW. Cancer epigenetics comes of age. Nature Genet 1999; 21: 163-67.10.1038/5947Search in Google Scholar

Honorio S, Agathanggelou A, Wernert N, Rothe M, Maher ER, Latif F. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours. Oncogene 2003; 22: 461-66.10.1038/sj.onc.1206119Search in Google Scholar

Chaubert P, Guillou L, Kurt A-M, Bertholet M-M, Metthez G, Leisinger H-J. Frequent p16^INK4 (MTS1) gene inactivation in testicular germ cell tumors. Am J Pathol 1997; 151: 859-65.Search in Google Scholar

Heidenreich A, Gaddipati JP, Moul JW, Srivastava S. Molecular analysis of P16^Ink4/CDKN2 and P15^Ink4B/MTS2 genes in primary human testicular germ cell tumors. J Urol 1998; 159: 1725-30.10.1097/00005392-199805000-00101Search in Google Scholar

Faulkner SW, Leigh DA, Oosterhuis JW, Roelofs H, Looijenga LHJ, Friedlander ML. Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model. Br J Cancer 2000; 83: 729-36.10.1054/bjoc.2000.1334Search in Google Scholar

Vladušić T, Hrašćan R, Vrhovac I, Krušlin B, Gamulin M, Grgić M, et al. Loss of heterozygosity of selected tumor suppressor genes in human testicular germ cell tumors. Pathol Res Pract 2010; 206: 163-7.10.1016/j.prp.2009.10.007Search in Google Scholar

Jones RH, Vasey PA. New directions in testicular cancer; molecular determinants of oncogenesis and treatment success. Eur J Cancer 2003; 39: 147-56.10.1016/S0959-8049(02)00612-3Search in Google Scholar

Strohmeyer T, Reissmann P, Cordon-Cardo C, Hartmann M, Ackermann R, Slamon D. Correlation between retinoblastoma gene expression and differentiation in human testicular tumors. Proc Natl Acad Sci 1991; 88: 6662-6.10.1073/pnas.88.15.6662Search in Google Scholar

Peng H-Q, Bailey D, Bronson D, Goss PE, Hogg D. Loss of heterozygosity of tumor suppressor genes in testis cancer. Cancer Res 1995; 55: 2871-75.Search in Google Scholar

Rothe M, Albers P, Wernert N. Loss of heterozygosity, differentiation, and clonality in microdissected male germ cell tumours. J Pathol 1999; 188: 389-94.10.1002/(SICI)1096-9896(199908)188:4<389::AID-PATH364>3.0.CO;2-KSearch in Google Scholar

Heidenreich A, Sesterhenn IA, Mostof FK, Moul JW. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer 1998; 83: 1002-11.10.1002/(SICI)1097-0142(19980901)83:5<1002::AID-CNCR27>3.0.CO;2-ASearch in Google Scholar

Bartkova J, Falck J, Rajpert-De Meyts E, Skakkebæk NE, Lukas J, Bartek J. Chk2 tumor suppressor protein in human spermatogenesis and testicular germ-cell tumours. Oncogene 2001; 20: 5897-902.10.1038/sj.onc.1204746Search in Google Scholar

Kamensek U, Sersa G. Targeted gene therapy in radiotherapy. Radiol Oncol 2008; 42: 115-35.10.2478/v10019-008-0009-1Search in Google Scholar